ANGPTL4 and breast cancer: To further assess whether ANGPTL4 and its downstream signaling pathways influence clinical outcomes in human breast cancer, we analyzed several annotated breast tumor datasets to compare ANGPTL4 expression across different breast cancer subtypes and among patients with varying body mass index (BMI).